Melissa DePaoli Johnson, PharmD

Associate Professor in Medicine
Department / Division:
Medicine / Medicine-Infectious Diseases
Room 173 Hanes House
315 Trent Drive
Durham, NC 27710
Office Telephone:
(919) 684-2374
  • PharmD, Campbell University, 1997
Research Interests:
Prognostic indicators for patients with Candida spp. bloodstream infections
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Representative Publications:
  • Johnson, MD; MacDougall, C; Ostrosky-Zeichner, L; Perfect, JR; Rex, JH. Combination antifungal therapy. Antimicrobial agents and chemotherapy. 2004;48:693-715.  Abstract
  • Johnson, MD; Hamilton, CD; Drew, RH; Sanders, LL; Pennick, GJ; Perfect, JR. A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution. Journal of Antimicrobial Chemotherapy. 2003;51:453-457.  Abstract
  • Johnson, MD; Perfect, JR. Caspofungin: first approved agent in a new class of antifungals. Expert Opinion on Pharmacotherapy. 2003;4:807-823.  Abstract
  • Bohjanen, PR; Johnson, MD; Szczech, LA; Wray, DW; Petros, WP; Miller, CR; Hicks, CB. Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis. Antimicrobial agents and chemotherapy. 2002;46:2387-2392.  Abstract
  • Johnson, MD; Perfect, JR. Fungal Infections of the Bones and Joints. Current Infectious Disease Reports. 2001;3:450-460.  Abstract
  • Johnson, MD; Drew, RH; Perfect, JR. Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature. Pharmacotherapy. 1998;18:1053-1061.  Abstract
end fo content area